Max Robotics — Global Service Robot Directory + US Certification

About

Lee Hartner is a leading surgical oncologist whose research focuses on refining treatment paradigms for human papillomavirus-related (HPV+) head and neck cancers, with a particular emphasis on transoral robotic surgery (TORS). His major contributions center on characterizing recurrence patterns and developing predictive models for lethal outcomes after TORS, a minimally invasive approach increasingly used for HPV+ oropharyngeal tumors. Hartner’s landmark 2022 study, which has garnered 16 citations, established a benchmark for oncologic outcomes and created a novel model to stratify lethal recurrence risk, directly addressing a critical gap in post-surgical prognostication. His earlier 2021 work further profiled recurrence patterns, identifying key features—such as extranodal extension and smoking history—that predict aggressive, fatal disease. By integrating clinical and pathological variables, Hartner’s research empowers clinicians to tailor adjuvant therapy and surveillance intensity, potentially improving survival while reducing overtreatment. His findings have been presented at major oncology meetings, underscoring their clinical relevance. For students and researchers, Hartner’s work exemplifies how surgical outcomes research can translate into actionable risk stratification tools, bridging the gap between operative technique and precision oncology in HPV+ head and neck cancer care.